We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.15%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
–
Cap. Flow
+$97.1M
Cap. Flow
% of AUM
93.05%
Top 10 Holdings %
Top 10 Hldgs %
4.92%
Holding
1,330
New
1,330
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRC Group Holdings
RILY
|
+$733K |
| 2 |
iHeartMedia
IHRT
|
+$672K |
| 3 |
Taysha Gene Therapies
TSHA
|
+$581K |
| 4 |
NextDecade
NEXT
|
+$540K |
| 5 |
Appian
APPN
|
+$466K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.72% |
| 2 | Technology | 15.99% |
| 3 | Industrials | 14.77% |
| 4 | Financials | 13.46% |
| 5 | Consumer Discretionary | 12.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vivid Seats
SEAT
$72.5M
| $304K | 0.29% |
+2,404
| New | +$329K |
|
27
Nelnet
NNI
$4.73B
| $298K | 0.29% |
+3,381
| New | +$293K |
|
28
Corcept Therapeutics
CORT
$10.4B
| $292K | 0.28% |
+8,984
| New | +$247K |
|
|
YMAB
29
DELISTED
Y-mAbs Therapeutics
YMAB
| $286K | 0.27% |
+41,949
| New | +$243K |
|
30
Adeia
ADEA
$2.97B
| $283K | 0.27% |
+22,859
| New | +$221K |
|
|
CDMO
31
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $281K | 0.27% |
+43,242
| New | +$279K |
|
32
Symbotic
SYM
$5.16B
| $275K | 0.26% |
+5,348
| New | +$234K |
|
33
IMAX
IMAX
$2.42B
| $273K | 0.26% |
+18,207
| New | +$312K |
|
34
Myers Industries
MYE
$1.16B
| $271K | 0.26% |
+13,854
| New | +$247K |
|
35
Astrana Health
ASTH
$2.03B
| $269K | 0.26% |
+7,031
| New | +$234K |
|
36
Johnson & Johnson
JNJ
$624B
| $269K | 0.26% |
+1,717
| New | +$263K |
|
37
NCR Voyix
VYX
$1.05B
| $260K | 0.25% |
+15,390
| New | +$245K |
|
|
TAST
38
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $259K | 0.25% |
+32,922
| New | +$224K |
|
39
James River Group Holdings
JRVR
$209M
| $258K | 0.25% |
+27,958
| New | +$321K |
|
40
Franklin Covey
FC
$236M
| $258K | 0.25% |
+5,930
| New | +$235K |
|
41
Mission Produce
AVO
$1.08B
| $256K | 0.25% |
+25,362
| New | +$236K |
|
42
Tootsie Roll Industries
TR
$2.85B
| $256K | 0.25% |
+8,407
| New | +$246K |
|
43
AtriCure
ATRC
$1.67B
| $255K | 0.24% |
+7,152
| New | +$266K |
|
44
Allegro MicroSystems
ALGM
$9.33B
| $252K | 0.24% |
+8,332
| New | +$238K |
|
45
Replimune Group
REPL
$878M
| $252K | 0.24% |
+29,862
| New | +$346K |
|
46
United Fire Group
UFCS
$1.27B
| $251K | 0.24% |
+12,456
| New | +$253K |
|
47
Vertiv
VRT
$117B
| $249K | 0.24% |
+5,192
| New | +$221K |
|
48
Gogo Inc
GOGO
$510M
| $248K | 0.24% |
+24,508
| New | +$260K |
|
49
Axcelis
ACLS
$4.35B
| $248K | 0.24% |
+1,913
| New | +$264K |
|
50
KKR & Co
KKR
$86.2B
| $247K | 0.24% |
+2,980
| New | +$202K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
GAM
KFSC
YCM
EntryPoint Capital's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for EntryPoint Capital, which disclosed 1,330 positions worth $104M. Its ten largest holdings account for 4.9% of the portfolio.
Its largest position is BRC Group Holdings: 25,051 shares worth $526K.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Technology and Industrials.
- EntryPoint Capital's largest Q4 2023 buy was BRC Group Holdings: 25,051 shares worth $526K.
- EntryPoint Capital's ten largest holdings make up 4.9% of its $104M portfolio in Q4 2023.
- EntryPoint Capital disclosed 1,330 positions in Q4 2023, its first 13F filing on record.
Based on EntryPoint Capital's 13F filing for Q4 2023, filed 14 Feb 2024.